CWM
RYTM icon

CIBC World Markets’s Rhythm Pharmaceuticals RYTM Stock Holding History

CIBC World Markets’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$375K Buy
+3,502
New +$371K ﹤0.01% 888
2025
Q2 		$424K Sell
6,706
-5,442
-45% -$333K ﹤0.01% 939
2025
Q1 		$643K Buy
12,148
+7,025
+137% +$390K 0.01% 886
2024
Q4 		$287K Buy
+5,123
New +$283K ﹤0.01% 953

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIBC World Markets's RYTM Position: Q4 2025 in Review

CIBC World Markets opened a new position in Rhythm Pharmaceuticals (RYTM) in Q4 2025: 3,502 shares worth $375K. The stake represents ﹤0.01% of the portfolio and ranks #888 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in RYTM as recently as Q2 2025.

CIBC World Markets first reported a position in RYTM in Q4 2024 and has held it in 4 quarters since. The position peaked at $643K in Q1 2025. 279 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

  • CIBC World Markets held 3,502 shares of Rhythm Pharmaceuticals worth $375K as of Q4 2025.
  • Rhythm Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Rhythm Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #888 holding.
  • CIBC World Markets first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Rhythm Pharmaceuticals position peaked at $643K in Q1 2025.
  • 279 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.